Prof. Dr. Alfred Mahr
29.09.2020
Use and reporting of outcome measures in randomized trials for anti-neutrophil cytoplasmic antibody-associated vasculitis: a systematic literature review
Monti S, Merkel P, Viðarsdóttir M, Pagnoux C, Mahr A, Lanier G, Langford C, Jayne D, Christensen R, Quinn K, Tomasson G. Use and reporting of outcome measures in randomized trials for anti-neutrophil cytoplasmic antibody-associated vasculitis: a systematic literature review. Semin Arthritis Rheum 2020; 50:1314-1325.
29.09.2020Use and reporting of outcome measures in randomized trials for anti-neutrophil cytoplasmic antibody-associated vasculitis: a systematic literature review
29.09.2020Semin Arthritis Rheum 2020; 50:1314-1325
Monti Sara, Merkel Peter A, Viðarsdóttir Maria Bjork, Pagnoux Christian, Mahr Alfred, Lanier Georgia E, Langford Carol, Jayne David, Christensen Robin, Quinn Kaitlin A, Tomasson Gunnar
Weiter
01.01.2020
Comment on: Subclassifying ANCA-associated vasculitis: a unifying view of disease spectrum: reply
Mahr A, Specks U, Jayne D. Comment on: Subclassifying ANCA-associated vasculitis: a unifying view of disease spectrum: reply. Rheumatology (Oxford) 2020; 59:1187.
01.01.2020Comment on: Subclassifying ANCA-associated vasculitis: a unifying view of disease spectrum: reply
01.01.2020Rheumatology (Oxford) 2020; 59:1187
Mahr Alfred, Specks Ulrich, Jayne David
Weiter